[Relationship between the polysomnography and body mass index in children]

Ruiqing Liu1, Jianyun Li, Fan Lou

  • 1Department of Otolaryngology, Children's Hospital of Kunming, Kunming, 650034, China. lighting-liu@163.com

Insights

Pediatric obstructive sleep apnea hypopnea syndrome impacts children's growth. Diagnosis is suggested at an apnea-hypopnea index (AHI) greater than or equal to 2 for operative standards.

Area of Science:

  • Pediatric Sleep Medicine
  • Child Growth and Development
  • Respiratory Medicine

Context:

  • Obstructive sleep apnea hypopnea syndrome (OSAHS) is a prevalent condition in children.
  • Growth disturbances are a potential consequence of pediatric OSAHS.
  • Establishing clear diagnostic and operative criteria for pediatric OSAHS is crucial.

Purpose:

  • To investigate the relationship between OSAHS severity and growth parameters in children.
  • To determine appropriate diagnostic thresholds for pediatric OSAHS based on objective measures.
  • To inform operative decision-making for children with OSAHS.

Summary:

  • A study involving 582 children (2.5-10 years) utilized polysomnography (PSG) to assess the apnea-hypopnea index (AHI).
  • Significantly different body mass index (BMI) was observed in boys with AHI ≥ 2 and girls with AHI ≥ 1 compared to controls.
  • These findings suggest an AHI threshold of ≥ 2 for diagnosing pediatric OSAHS and guiding surgical interventions.

Impact:

  • Provides evidence-based recommendations for the diagnosis and management of pediatric OSAHS.
  • Highlights the importance of PSG in evaluating growth impacts of sleep-disordered breathing.
  • Aims to improve clinical outcomes for children affected by obstructive sleep apnea hypopnea syndrome.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...